Related references
Note: Only part of the references are listed.CD8+T-bet+ cells as a predominant biomarker for inclusion body myositis
Gaelle Dzangue-Tchoupou et al.
AUTOIMMUNITY REVIEWS (2019)
Highly differentiated cytotoxic T cells in inclusion body myositis
Steven A. Greenberg et al.
BRAIN (2019)
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
Michael G. Hanna et al.
LANCET NEUROLOGY (2019)
Health care costs and comorbidities for patients with inclusion body myositis
Allison Keshishian et al.
CURRENT MEDICAL RESEARCH AND OPINION (2018)
Canonical signaling and nuclear activity of mTORa teamwork effort to regulate metabolism and cell growth
Vincent Giguere
FEBS JOURNAL (2018)
Analysis of cell surface and intranuclear markers on non-stimulated human PBMC using mass cytometry
Gaelle Dzangue-Tchoupou et al.
PLOS ONE (2018)
A study of target effect sizes in randomised controlled trials published in the Health Technology Assessment journal
Joanne C. Rothwell et al.
TRIALS (2018)
Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum
Simon Rothwell et al.
ARTHRITIS & RHEUMATOLOGY (2017)
MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study
Jasper M. Morrow et al.
LANCET NEUROLOGY (2016)
Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken
Olivier Benveniste et al.
ACTA NEUROPATHOLOGICA (2015)
mTOR signaling promotes a robust and continuous production of IFN-gamma by human memory CD8(+) T cells and their proliferation
Ruka Setoguchi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
mTOR: a pharmacologic target for autophagy regulation
Young Chul Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Validation of a Generic Approach to Muscle Water T2 Determination at 3T in Fat-Infiltrated Skeletal Muscle
Noura Azzabou et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2015)
Rapamycin attenuates mitochondrial dysfunction via activation of mitophagy in experimental ischemic stroke
Qiang Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Evaluation and construction of diagnostic criteria for inclusion body myositis
Thomas E. Lloyd et al.
NEUROLOGY (2014)
Sleep disordered breathing and subclinical impairment of respiratory function are common in sporadic inclusion body myositis
Pedro M. Rodriguez Cruz et al.
NEUROMUSCULAR DISORDERS (2014)
Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: Implications for therapeutic trials
Jean-Yves Hogrel et al.
NEUROMUSCULAR DISORDERS (2014)
Cytosolic 5′-nucleotidase 1A autoimmunity in sporadic inclusion body myositis
H. Benjamin Larman et al.
ANNALS OF NEUROLOGY (2013)
Modifying the Medical Research Council grading system through Rasch analyses
Els Karla Vanhoutte et al.
BRAIN (2012)
Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis
Yves Allenbach et al.
NEUROMUSCULAR DISORDERS (2012)
Long-term observational study of sporadic inclusion body myositis
Olivier Benveniste et al.
BRAIN (2011)
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
Greg M. Delgoffe et al.
NATURE IMMUNOLOGY (2011)
Theories of the Pathogenesis of Inclusion Body Myositis
Steven A. Greenberg
Current Rheumatology Reports (2010)
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
David E. Harrison et al.
NATURE (2009)
Phenotype and Function of Human T Lymphocyte Subsets: Consensus and Issues
Victor Appay et al.
CYTOMETRY PART A (2008)
The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
Sokol Haxhinasto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Inclusion body myositis functional rating scale: A reliable and valid measure of disease severity
C. E. Jackson et al.
MUSCLE & NERVE (2008)
β-amyloid is a substrate of autophagy in sporadic inclusion body myositis
Jan D. Lunemann et al.
ANNALS OF NEUROLOGY (2007)
Mitochondrial abnormalities in inclusion-body myositis
A Oldfors et al.
NEUROLOGY (2006)
Inclusion-body myositis - A myodegenerative conformational disorder associated with A beta, protein misfolding, and proteasome inhibition
V Askanas et al.
NEUROLOGY (2006)
Share Paper
